|
Spotlight on Lisa Hall and Team “The Little Leprechaun’s Lucky Charms”
|
|
Why We’re Walking the Walk to Make Myeloma Matter:
"We lost Les to multiple myeloma on Sunday May 7, 2017 at exactly 7pm. 777 is the number for Luck, and it will be our team number as we march in his behalf."
|
|
|
|
Saturday, June 24, 1:00pm EST
|
|
|
Reminder:
Register Now for Myeloma Canada’s
Educational Webinar
|
|
Managing Side Effects Featuring,
Cindy Manchulenko
Clinical Trials Project Manager, Clinical & Systems Transformation and Member of the Myeloma Canada Board of Directors
For patients and caregivers, learn more on how to better manage myeloma symptoms and the side-effects of treatments and medications.
|
|
|
Take a Step Towards a Cure in Ottawa!
|
|
|
R
egister for the Ottawa-Gatineau Myeloma Walk on September and take a step towards a cure for multiple myeloma!
Supporting Myeloma Canada and the Ottawa General Hospital, the Walk will not only increase awareness of the disease but help fund clinical research for Canadian patients living with myeloma.
|
|
|
 |
|
I Turned my Cancer Diagnosis into a Passion for Helping Others
"I recently celebrated my 15th year living with multiple myeloma, and can attest to the positive outlook for the future of others living with this condition."
Aldo Del Col, Co-founder and Chairman of Myeloma Canada.
Thank you Huff Post Canada for the Great Article!
|
|
|
|
Collaboration Is Essential To Revitalizing Health Care In Canada
Despite being an innovative nation, many patients in Canada still struggle to access life-saving medications.
“Drug coverage was not mandated as part of universal health care, and that’s the genesis of the problem we have”
Sending a powerful message to Canadians, this article was p
ublished within the Maclean’s Canada 150 Special Issue, now on newsstands.
|
|
|
|
|
The Myeloma Canada Research Network
Welcomes
Julia Dobbins to the Team
|
|
The Myeloma Canada Research Network (MCRN) is delighted to announce the addition of Julia Dobbins to its team as a Clinical Trial Specialist.
In this role, Julia will be responsible for coordinating all aspects of MCRN’s clinical trial activities. Prior to joining MCRN, Julia worked for McKesson Canada, a large healthcare services company, where she was involved in project management support and the administration of patient support programs. Her goal in this capacity was to reduce financial barriers that patients faced when they were prescribed biologics/specialty medications. Julia then moved on to clinical research as a site monitor on large, multi-centre late phase trials. She has experience in many different therapeutic areas such as ophthalmology, psychiatry, cystic fibrosis, immunology, and oncology.
Julia has a bachelor of health sciences from Western University and a graduate certificate in clinical research from the Michener Institute in Toronto.
|
|
|
Taking Action for Early Diagnosis:
Myeloma Canada Educates Primary Care Physicians About Myeloma and its Early Symptoms at the Pri-Med Canada Conference
|
|
As many patients and caregivers can attest to, getting an early diagnosis is key to improving patient outcomes and improving overall quality of life. As part of the early diagnosis program, Myeloma Canada as well as patients living with myeloma attend family medicine conferences to raise awareness with family doctors and increase knowledge of myeloma and its early symptoms.
On May 10-13, Myeloma Canada was among the 200 exhibitors at the Pri-Med Canada (PMC) Conference in Toronto. The PMC is the largest annual continuing medical education conference in Canada where thousands of family physicians, pharmacists, nurse practitioners, registered nurses and medical students are in attendance to advance their knowledge in primary care.
Thank you to volunteers Patrick Taylor, David and Erika McMullen, Norma Lindner, Leslie Weatherby, Robert McCaw and Juliette Royer for representing Myeloma Canada and the Canadian myeloma community, for putting myeloma on the map in primary care.
Pictured above: Juliette Royer (left) and Norma Lindner (right)
|
|
|
Panelists from left to right: Bruce Williamson, Vice President, Sales & Marketing - Janssen Inc., Linda Eagen, Founder, Cancer Coaching - President & CEO, Ottawa Regional Cancer Foundation, Lorelei Dalrymple, Chair - Myeloma Canada Patient Advisory Council, Darrell White, MD, Senior Associate Dean Professor of Medicine - Dalhousie University, Pamela Fralick, President - Innovative Medicines Canada
|
|
|
Economic Club of Canada Luncheon Highlights
Excellent afternoon spent at the Economic Club of Canada Luncheon in Ottawa on May 31st, to discuss the importance of innovative medicines in treating cancer. Important questions were asked, discussion lines were opened and excellent insight was gained. With the patient voice at the center of the debate, all the panelists agreed that access to new and innovative medicines for treating cancer in Canada needs improvement and we need to find better ways to work together as a community to streamline this process. Panelist Dr. Darrell White, Hematologist/Oncologist and Chair of the Myeloma Canada Research Network (MCRN) exemplified Myeloma Canada and the MCRN as organizations that are successfully paving the way to improving patient care by providing access to innovative medicines through Canadian-designed clinical trials and unifying the voice of the Canadian myeloma community.
Thank you to all of the expert panelists who led the armchair discussions, Natasha Morano for organizing this worthwhile event, as well as myeloma representatives Lorelei Dalrymple, patient and Chair of the Myeloma Canada Patient Advisory Council and Dr Darrell White, MD, MSc, FRCPC, FACP, Senior Associate Dean, Faculty of Medicine, QEII Health Sciences Center and Dalhousie University, Halifax, NS.
|
|
|
|
Summer events have begun!
Find out what’s happening in the Canadian myeloma community with golf tournaments, pancake breakfasts, InfoSessions and more.
|
|
|
|
|
Last Chance to Support Myeloma Canada in the The Great Canadian Giving Challenge!
For the entire month of June, every $1 you donate to Myeloma Canada through Canada Helps qualifies us to win $10,000! The more you give, the more chances for us to win!
The winner will be announced on July 1st, Canada's birthday!
|
|
|
|
Walk the Walk.
Make Myeloma Matter.
Join the 2017 Multiple Myeloma March and help fund clinical research and support advocacy for accelerated access to game-changing therapies for Canadian patients living with myeloma.
To register or donate, visit
** NEW IN 2017**
Get your training shoes on and turn your walk into a 5 km run!
Whether you're walking, running or rolling for the cause, we'll support you every step of the way.
|
|
|
|
|
|
|
